George Onyango C, Ogonda L, Guyah B
Infect Agent Cancer. 2025; 20(1):11.
PMID: 39994762
PMC: 11853817.
DOI: 10.1186/s13027-024-00620-4.
Adewumi K, Kachoria A, Adoyo E, Rop M, Owaya A, Tang J
Front Reprod Health. 2025; 7:1487264.
PMID: 39980670
PMC: 11839715.
DOI: 10.3389/frph.2025.1487264.
Maloba M, Finocchario-Kessler S, Wexler C, Staggs V, Maosa N, Babu S
PLoS One. 2025; 20(2):e0318941.
PMID: 39965035
PMC: 11835318.
DOI: 10.1371/journal.pone.0318941.
Maseko A, Silumbwe A, Maritim P, Munakampe M, Chirambo G, Jacobs C
BMC Health Serv Res. 2025; 25(1):213.
PMID: 39915793
PMC: 11800521.
DOI: 10.1186/s12913-025-12367-8.
Anangwe N, Steimgrimson J, Cu-Uvin S
BMC Cancer. 2025; 25(1):203.
PMID: 39910487
PMC: 11796189.
DOI: 10.1186/s12885-025-13563-9.
The Potential Impact of a Single-Dose HPV Vaccination Schedule on Cervical Cancer Outcomes in Kenya: A Mathematical Modelling and Health Economic Analysis.
Umutesi G, Hathaway C, Heitner J, Jackson R, Miano C, Mugambi W
Vaccines (Basel). 2024; 12(11).
PMID: 39591151
PMC: 11598770.
DOI: 10.3390/vaccines12111248.
Women's experiences and acceptability of self-administered, home delivered, intravaginal 5-Fluorouracil cream for cervical precancer treatment in Kenya.
Adewumi K, Kachoria A, Adoyo E, Rop M, Owaya A, Tang J
medRxiv. 2024; .
PMID: 39568790
PMC: 11577251.
DOI: 10.1101/2024.08.27.24312651.
Optical imaging for screening and early cancer diagnosis in low-resource settings.
Richards-Kortum R, Lorenzoni C, Bagnato V, Schmeler K
Nat Rev Bioeng. 2024; 2(1):25-43.
PMID: 39301200
PMC: 11412616.
DOI: 10.1038/s44222-023-00135-4.
Evaluation of Pathology Resources for Cervical Cancer Detection Between 2018 & 2022: a Retrospective Study at Moi Teaching and Referral Hospital, Western Kenya.
Anangwe N, Steimgrimson J, Cu-Uvin S
Res Sq. 2024; .
PMID: 39257969
PMC: 11384803.
DOI: 10.21203/rs.3.rs-4791370/v1.
Men's perceptions and perceived acceptability of their female partner's use of self-administered intravaginal therapies for treatment of cervical precancer in Kenya.
Mungo C, Adewumi K, Ellis G, Rop M, Adoyo E, Zou Y
Ecancermedicalscience. 2024; 18:1719.
PMID: 39021542
PMC: 11254395.
DOI: 10.3332/ecancer.2024.1719.
Cost-effectiveness of single-visit cervical cancer screening in KwaZulu-Natal, South Africa: a model-based analysis accounting for the HIV epidemic.
Tran J, Hathaway C, Broshkevitch C, Palanee-Phillips T, Barnabas R, Rao D
Front Oncol. 2024; 14:1382599.
PMID: 38720798
PMC: 11077327.
DOI: 10.3389/fonc.2024.1382599.
Perceived acceptability of self-administered topical therapy for cervical precancer treatment among women undergoing cervical cancer screening in Kenya.
Mungo C, Ellis G, Rop M, Zou Y, Omoto J, Rahangdale L
medRxiv. 2024; .
PMID: 38585806
PMC: 10996722.
DOI: 10.1101/2024.03.05.24303779.
"ARVs is for HIV and cream is for HPV or precancer:" Women's Perceptions and Perceived Acceptability of Self-Administered Topical Therapies for Cervical Precancer Treatment: A Qualitative Study from Kenya.
Mungo C, Kachoria A, Adoyo E, Zulu G, Goraya S, Omoto J
medRxiv. 2024; .
PMID: 38559146
PMC: 10980133.
DOI: 10.1101/2024.03.11.24304083.
"There is nothing that can prevent me from supporting her:" men's perspectives on their involvement and support of women's use of topical therapy for cervical precancer treatment in Kenya.
Mungo C, Adewumi K, Adoyo E, Zulu G, Goraya S, Ogollah C
Front Oncol. 2024; 14:1360337.
PMID: 38532929
PMC: 10964769.
DOI: 10.3389/fonc.2024.1360337.
Men's perceptions and perceived acceptability of their female partner's use of self-administered intravaginal therapies for treatment of cervical precancer in Kenya.
Mungo C, Adewumi K, Ellis G, Rop M, Adoyo E, Zou Y
medRxiv. 2024; .
PMID: 38370772
PMC: 10871376.
DOI: 10.1101/2024.02.06.24302397.
State of the Science of Scale-Up of Cancer Prevention and Early Detection Interventions in Low- and Middle-Income Countries: A Scoping Review.
Friebel-Klingner T, Alvarez G, Lappen H, Pace L, Huang K, Fernandez M
JCO Glob Oncol. 2024; 10:e2300238.
PMID: 38237096
PMC: 10805431.
DOI: 10.1200/GO.23.00238.
"There is nothing that can prevent me from supporting her:" Men's perspectives on their involvement and support of women's use of topical therapy for cervical precancer treatment in Kenya.
Mungo C, Adewumi K, Adoyo E, Zulu G, Goraya S, Ogollah C
medRxiv. 2024; .
PMID: 38234805
PMC: 10793535.
DOI: 10.1101/2023.12.22.23300455.
Implementation and scale-up of a single-visit, screen-and-treat approach with thermal ablation for sustainable cervical cancer prevention services: a protocol for a stepped-wedge cluster randomized trial in Kenya.
Shin M, Oluoch L, Barnabas R, Baynes C, Fridah H, Heitner J
Implement Sci. 2023; 18(1):26.
PMID: 37365575
PMC: 10294443.
DOI: 10.1186/s13012-023-01282-3.
Concurrent HPV DNA testing and a visual inspection method for cervical precancer screening: A practical approach from Battor, Ghana.
Effah K, Tekpor E, Wormenor C, Amuah J, Essel N, Atuguba B
PLOS Glob Public Health. 2023; 3(4):e0001830.
PMID: 37079498
PMC: 10118129.
DOI: 10.1371/journal.pgph.0001830.
Modelling cervical cancer elimination using single-visit screening and treatment strategies in the context of high HIV prevalence: estimates for KwaZulu-Natal, South Africa.
Rao D, Bayer C, Liu G, Chikandiwa A, Sharma M, Hathaway C
J Int AIDS Soc. 2022; 25(10):e26021.
PMID: 36225139
PMC: 9557021.
DOI: 10.1002/jia2.26021.